Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies (NCT06458712) | Duke Street Bio Ltd | 2024-11-21 |
Track Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency) automatically
Every clearance here is in the API, with alerts when new ones post.